ENTITY

Concord Biotech (CONCORDB IN)

31
Analysis
Industrials • India
Concord Biotech is a biopharmaceutical company specializing in the research, development, manufacture, and sale of fermentation-based Active Pharmaceutical Ingredients (APIs) and high-quality finished formulations. The company's products span therapeutic areas such as immunosuppressants, oncology, antifungal, and antibacterial treatments. Concord Biotech was founded in 1984 and is headquartered in Ahmedabad, Gujarat, India.
more
•30 Aug 2023 06:20

AMFI Stock Reclassification Preview (Dec 2023): Overlap Between Active & Passive Flows

We see 42 potential migrations between the size categories. The small to mid migrations have outperformed. There will be a lot of overlap between...

Logo
731 Views
Share
bullish•Tencent
•20 Aug 2023 08:45

ECM Weekly (20th August 2023) - Indigo, Vinfast, SBFC, Concord, Wuxi, NSDL, LianLian, Fedbank

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
598 Views
Share
bullish•Concord Biotech
•17 Aug 2023 13:19

Concord Biotech IPO Trading - Strong Subscription Rates, Peers Have Moved up Since Last Note

Concord Biotech Ltd (658823Z IN) raised US$188m in its India IPO. In this note, we will talk about the trading dynamics.

Logo
607 Views
Share
bullish•Tencent
•06 Aug 2023 10:33

ECM Weekly (6th August 2023) - Concord Biotech, SBFC Fin, Fadu, Mitsui Fudosan, Capitaland Ascott

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
639 Views
Share
bullish•Concord Biotech
•04 Aug 2023 10:43

Concord Biotech IPO - Peer Comparison & Valuation - Smaller in Scale but Wider in Margins

Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO. In this note, we will undertake a peer comparison, and share...

Logo
1.1k Views
Share
x